RxSight (RxSight) Debt-to-Equity : 0.02 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is RxSight Debt-to-Equity?

RxSight's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.6 Mil. RxSight's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.9 Mil. RxSight's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $163.9 Mil. RxSight's debt to equity for the quarter that ended in Mar. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for RxSight's Debt-to-Equity or its related term are showing as below:

RXST' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.14 Med: 0.15 Max: 0.5
Current: 0.02

During the past 5 years, the highest Debt-to-Equity Ratio of RxSight was 0.50. The lowest was -0.14. And the median was 0.15.

RXST's Debt-to-Equity is ranked better than
91.65% of 707 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs RXST: 0.02

RxSight Debt-to-Equity Historical Data

The historical data trend for RxSight's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RxSight Debt-to-Equity Chart

RxSight Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-0.02

-0.10

0.33

0.50

0.02

RxSight Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial													0.31	0.15	0.02	0.02	0.02

Competitive Comparison of RxSight's Debt-to-Equity

For the Medical Devices subindustry, RxSight's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RxSight's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RxSight's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where RxSight's Debt-to-Equity falls into.

RxSight Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

RxSight's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.801	+	1.211)	/	160.362
	=	0.02

RxSight's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.614	+	0.908)	/	163.929
	=	0.02

RxSight (NAS:RXST) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

RxSight Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of RxSight's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

RxSight (RxSight) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RxSight Inc (NAS:RXST) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Columbia, Aliso Viejo, CA, USA, 92656

Website

https://www.rxsight.com

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

Executives

Ilya Goldshleger	officer: Chief Operating Officer	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Eric Weinberg	officer: Chief Commercial Officer	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Jesse Anderson Corley	director	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Kurtz Ronald M Md	director, officer: See Remarks	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Robert Keith Warner	director	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Shelley B Thunen	officer: Chief Financial Officer	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Bakker Juliet Tammenoms	director	LONGITUDE CAPITAL MANAGEMENT CO., LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Tamara Fountain	director	C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Robert J Palmisano	director	110 HARTWELL AVENUE, LEXINGTON MA 02173
Link William J Phd	director, 10 percent owner	ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Julie Andrews	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Rajeev M. Shah	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p.	10 percent owner	200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116